Signals Analytics

Signals Analytics was a private software and analytics company that developed the Signals Playbook platform, which used machine learning, natural language processing, and data automation to transform large volumes of external and unstructured data into actionable commercial insights. The company served consumer goods, pharmaceuticals, and other enterprise markets, helping customers with product strategy, innovation, portfolio optimization, and market intelligence. In life sciences, it worked on commercial and strategic analytics rather than drug discovery or therapeutic development, including collaborations tied to pharma market intelligence offerings. Signals Analytics was founded in 2009, headquartered in New York, and backed by venture investors including Sequoia Capital, Qumra Capital, Pitango Growth, and TPY Capital. The company was acquired by Kenshoo, which later rebranded as Skai, and its standalone operating status is listed as closed/acquired.